Cabinet okays FDI of up to Rs 9,589 crore for 76.1% stake in Hyderabad-based Suven Pharma
The Cabinet Committee on Economic Affairs (CCEA) has approved a foreign direct investment (FDI) of up to Rs 9,589 crore by Cyprus-based Berhyanda Ltd in Hyderabad-based Suven Pharmaceuticals Ltd for a 76.1% interest. Advent Funds, operated by US-based private equity firm Advent International Corporation, own the Cyprus-based corporation.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
